Profile data is unavailable for this security.
About the company
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus. Its product development programs are in non-clinical stages of development.
- Revenue in USD (TTM)185.00k
- Net income in USD-5.57m
- Incorporated1992
- Employees4.00
- LocationTitan Pharmaceuticals IncSUITE 505, 400 OYSTER POINT BLVDSAN FRANCISCO 94080United StatesUSA
- Phone+1 (415) 244-4990
- Fax+1 (650) 244-4956
- Websitehttps://www.titanpharm.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Healthy Extracts Inc | 2.49m | -2.47m | 5.93m | -- | -- | 6.19 | -- | 2.38 | -0.8588 | -0.8588 | 0.8611 | 0.3231 | 0.918 | 0.4921 | 36.50 | -- | -91.32 | -53.78 | -174.02 | -146.65 | 65.90 | 45.68 | -99.48 | -87.53 | 0.1636 | -9.72 | 0.5245 | -- | 10.41 | 105.93 | -151.54 | -- | -- | -- |
Biofrontera Inc | 34.07m | -20.13m | 5.95m | 85.00 | -- | 0.3705 | -- | 0.1748 | -15.19 | -15.19 | 24.30 | 3.16 | 0.8646 | 1.93 | 5.42 | 400,858.80 | -51.08 | -- | -101.07 | -- | 48.80 | -- | -59.08 | -- | 0.6727 | -2.71 | 0.4489 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
Hoth Therapeutics Inc | 0.00 | -7.85m | 5.96m | 2.00 | -- | 0.6018 | -- | -- | -2.44 | -2.44 | 0.00 | 2.03 | 0.00 | -- | -- | 0.00 | -96.38 | -157.07 | -110.40 | -177.32 | -- | -- | -- | -- | -- | -50.23 | 0.00 | -- | -- | -- | 31.01 | -- | -- | -- |
Protagenic Therapeutics Inc | 0.00 | -5.00m | 5.97m | -- | -- | 1.63 | -- | -- | -1.15 | -1.15 | 0.00 | 0.8271 | 0.00 | -- | -- | -- | -80.91 | -74.49 | -94.48 | -92.56 | -- | -- | -- | -- | -- | -9.56 | 0.00 | -- | -- | -- | -40.64 | -- | -- | -- |
Lixte Biotechnology Holdings Inc | 0.00 | -5.09m | 6.01m | 3.00 | -- | 12.15 | -- | -- | -2.77 | -2.77 | 0.00 | 1.78 | 0.00 | -- | -- | 0.00 | -103.09 | -104.18 | -111.07 | -111.05 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 19.41 | -- | -- | -- |
Xenetic Biosciences Inc | 2.54m | -4.13m | 6.04m | 4.00 | -- | 0.6167 | -- | 2.38 | -2.70 | -2.70 | 1.66 | 6.36 | 0.2006 | -- | -- | 634,995.00 | -32.65 | -48.91 | -35.27 | -52.82 | -- | -- | -162.78 | -682.42 | -- | -- | 0.00 | -- | 48.80 | -- | 36.90 | -- | -- | -- |
Entero Therapeutics Inc | 0.00 | -16.10m | 6.06m | 15.00 | -- | 1.30 | -- | -- | -88.75 | -88.75 | 0.00 | 2.31 | 0.00 | -- | -- | 0.00 | -256.35 | -295.92 | -471.06 | -1,599.51 | -- | -- | -- | -- | -- | -790.91 | 0.1454 | -- | -- | -- | -7.55 | -- | -- | -- |
Vaxxinity Inc | 0.00 | -56.94m | 6.09m | 57.00 | -- | 0.4537 | -- | -- | -0.4499 | -0.4499 | 0.00 | 0.1058 | 0.00 | -- | -- | 0.00 | -75.56 | -- | -111.46 | -- | -- | -- | -- | -- | -- | -- | 0.5308 | -- | -- | -- | 24.31 | -- | -- | -- |
Soligenix Inc | 839.36k | -6.14m | 6.16m | 13.00 | -- | 1.60 | -- | 7.34 | -0.9164 | -0.9164 | 0.1085 | 0.243 | 0.0697 | -- | 5.86 | 64,566.15 | -51.01 | -75.40 | -872.23 | -154.32 | 11.59 | 22.83 | -731.60 | -620.02 | -- | -1,677.11 | 0.5639 | -- | -11.54 | -30.67 | 55.50 | -- | -- | -- |
Titan Pharmaceuticals Inc | 185.00k | -5.57m | 6.17m | 4.00 | -- | 0.7936 | -- | 33.33 | -7.40 | -7.40 | 0.246 | 8.50 | 0.0305 | -- | 4.51 | 46,250.00 | -91.72 | -96.80 | -138.02 | -156.65 | -- | -- | -3,010.27 | -406.26 | 5.55 | -- | 0.07 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
Longeveron Inc | 709.00k | -22.21m | 6.24m | 23.00 | -- | 3.06 | -- | 8.80 | -10.18 | -10.18 | 0.3262 | 0.4245 | 0.0359 | -- | 4.31 | 30,826.09 | -108.45 | -63.15 | -139.35 | -75.68 | 31.17 | 33.70 | -3,020.17 | -441.02 | -- | -- | 0.00 | -- | -41.98 | -19.78 | -17.92 | -- | 26.80 | -- |
Cell MedX Corp | 70.00 | -96.91k | 6.27m | 0.00 | -- | -- | -- | 89,595.54 | -0.0029 | -0.0029 | 0.00 | -0.0024 | 0.0015 | -- | -- | -- | -202.28 | -792.55 | -- | -- | -685.71 | -- | -138,442.90 | -3,681.84 | -- | -3.17 | -- | -- | -54.53 | -- | 29.01 | -- | -- | -- |
Enzon Pharmaceuticals Inc | 0.00 | 98.00k | 6.30m | 0.00 | 64.34 | 1.80 | -- | -- | 0.0013 | 0.0013 | 0.00 | 0.6197 | 0.00 | -- | -- | -- | 2.88 | -0.8654 | 2.99 | -0.8851 | -- | -- | -- | -159.43 | -- | -- | 0.00 | -- | -100.00 | -- | 106.71 | -55.86 | -- | -- |
Processa Pharmaceuticals Inc | 0.00 | -11.12m | 6.34m | 13.00 | -- | 0.5722 | -- | -- | -8.72 | -8.72 | 0.00 | 3.88 | 0.00 | -- | -- | 0.00 | -154.40 | -84.35 | -175.45 | -90.03 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
Reliv International Inc | 35.13m | -175.48k | 6.35m | 208.00 | -- | 0.9165 | 15.88 | 0.1808 | -0.1005 | -0.1005 | 20.12 | 6.55 | 2.09 | 8.02 | 228.49 | -- | -1.05 | -4.65 | -1.47 | -6.06 | 40.90 | 41.98 | -0.4996 | -2.33 | 1.07 | -- | 0.1064 | -- | -2.94 | -9.37 | 76.65 | -- | -35.85 | -- |
Holder | Shares | % Held |
---|---|---|
Truist Bank (Private Banking)as of 31 Mar 2024 | 31.25k | 3.42% |
Tower Research Capital LLCas of 31 Mar 2024 | 647.00 | 0.07% |
MCF Advisors LLCas of 31 Mar 2024 | 165.00 | 0.02% |
Group One Trading LPas of 31 Mar 2024 | 12.00 | 0.00% |
BofA Securities, Inc.as of 31 Mar 2024 | 11.00 | 0.00% |
Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 6.00 | 0.00% |
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 5.00 | 0.00% |
American Portfolios Advisors, Inc.as of 31 Mar 2024 | 3.00 | 0.00% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 3.00 | 0.00% |
Global Wealth Strategies & Associates LLCas of 31 Mar 2024 | 2.00 | 0.00% |